MX2015011614A - Derivados de pirrolidina, composiciones farmaceuticas que los contienen, y su uso en terapia. - Google Patents

Derivados de pirrolidina, composiciones farmaceuticas que los contienen, y su uso en terapia.

Info

Publication number
MX2015011614A
MX2015011614A MX2015011614A MX2015011614A MX2015011614A MX 2015011614 A MX2015011614 A MX 2015011614A MX 2015011614 A MX2015011614 A MX 2015011614A MX 2015011614 A MX2015011614 A MX 2015011614A MX 2015011614 A MX2015011614 A MX 2015011614A
Authority
MX
Mexico
Prior art keywords
pyrrolidine derivatives
pharmaceutical compositions
therapy
compositions containing
relates
Prior art date
Application number
MX2015011614A
Other languages
English (en)
Inventor
Charles W Hutchins
Stevan W Djuric
Wilhelm Amberg
Udo Lange
Frauke Pohlki
Irini Zanze
Huan-Qiu Li
Anil Vasudevan
Yanbin Lao
Jason T Brewer
Ying X Wang
Hongyu H Zhao
Justin Dietrich
Original Assignee
Abbvie Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Deutschland filed Critical Abbvie Deutschland
Publication of MX2015011614A publication Critical patent/MX2015011614A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención se refiere a derivados de pirrolidina de la fórmula (I), (ver Fórmula) o una sal fisiológicamente tolerada de los mismos. La invención se refiere a composiciones farmacéuticas que comprenden tales derivados de pirrolidina, y el uso de tales derivados de pirrolidina para propósitos terapéuticos. Los derivados de pirrolidina son inhibidores GlyT1.
MX2015011614A 2013-03-15 2014-03-14 Derivados de pirrolidina, composiciones farmaceuticas que los contienen, y su uso en terapia. MX2015011614A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361789382P 2013-03-15 2013-03-15
US201361788538P 2013-03-15 2013-03-15
PCT/EP2014/055159 WO2014140310A1 (en) 2013-03-15 2014-03-14 Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

Publications (1)

Publication Number Publication Date
MX2015011614A true MX2015011614A (es) 2016-05-12

Family

ID=50280399

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011614A MX2015011614A (es) 2013-03-15 2014-03-14 Derivados de pirrolidina, composiciones farmaceuticas que los contienen, y su uso en terapia.

Country Status (8)

Country Link
EP (1) EP2970215B1 (es)
JP (1) JP2016514118A (es)
CN (1) CN105209457A (es)
AU (1) AU2014230122A1 (es)
BR (1) BR112015022758A2 (es)
CA (1) CA2900888A1 (es)
MX (1) MX2015011614A (es)
WO (1) WO2014140310A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101771219B1 (ko) 2015-08-21 2017-09-05 양지화학 주식회사 야누스 키나제 1 선택적 억제제 및 그 의약 용도
ES2877763T3 (es) 2016-09-20 2021-11-17 Glaxosmithkline Ip No 2 Ltd Antagonistas del trpv4
TW201825458A (zh) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產（第二）有限公司 Ｔｒｐｖ４拮抗劑
US10590077B2 (en) 2016-09-20 2020-03-17 Glaxosmithkline Intellectual Property Development Limited TRPV4 antagonists
CN110167930A (zh) * 2016-11-10 2019-08-23 百时美施贵宝公司 RORγ调节剂
CA3052479A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
CA3052480A1 (en) * 2017-02-17 2018-08-23 Trevena, Inc. 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
EP4054551A4 (en) * 2019-11-07 2024-03-20 Univ Illinois INFLUENZA VIRAL ENTRY INHIBITORS
CN115181093B (zh) * 2022-08-01 2023-04-25 重庆医科大学 Sunvozertinib中间体的制备方法
CN115181047B (zh) * 2022-08-01 2024-01-30 重庆医科大学 手性3 -(二甲氨基)吡咯烷的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867391A (en) * 1973-08-09 1975-02-18 Pfizer Cyclic n-substituted derivatives of 1,4-benzene disulphonamide
US7838518B2 (en) * 2002-02-12 2010-11-23 N.V. Organon 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
MXPA06000701A (es) * 2003-07-23 2006-04-11 Wyeth Corp Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6.
DE102005000666B3 (de) * 2005-01-04 2006-10-05 Sanofi-Aventis Deutschland Gmbh Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US8877794B2 (en) * 2010-08-13 2014-11-04 Abbott Laboratories Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Also Published As

Publication number Publication date
JP2016514118A (ja) 2016-05-19
WO2014140310A1 (en) 2014-09-18
EP2970215B1 (en) 2019-04-17
EP2970215A1 (en) 2016-01-20
AU2014230122A1 (en) 2015-08-06
BR112015022758A2 (pt) 2017-07-18
CA2900888A1 (en) 2014-09-18
CN105209457A (zh) 2015-12-30

Similar Documents

Publication Publication Date Title
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
UA105036C2 (uk) Амінотетралінові похідні, фармацевтична композиція, яка їх містить, і їх застосування в терапії
MX2015011614A (es) Derivados de pirrolidina, composiciones farmaceuticas que los contienen, y su uso en terapia.
MX2014006004A (es) Derivados de aminobenzociclohepteno, aminotetralina, aminoindano y fenalcilamina n-sustituidas, composiciones farmaceuticas que los contienen, y su uso en terapia.
MX2016004936A (es) Derivados de aminocromano, aminotiocromano y amino-1,2,3,4-tetrahi droquinilina, composiciones farmaceuticas que los contienen, y su uso en terapia.
PH12016500105A1 (en) Sulfonamides as modulators of sodium channels
WO2012020131A3 (en) Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
MX338515B (es) Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio.
MX2016004934A (es) Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
PH12014502605A1 (en) Uracyl spirooxetane nucleosides
MX2009014235A (es) 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso.
MX2015017964A (es) Inhibidores de bromodominio.
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
NZ710270A (en) Pyridone amides as modulators of sodium channels
EA201591371A1 (ru) Пиридиновые производные в качестве легкоразлагаемых ингибиторов rock
PH12016502355A1 (en) Pharmaceutical composition
NZ710111A (en) Quinoline and quinoxaline amides as modulators of sodium channels
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12018500446A1 (en) Pyridinone dicarboxamide for use as bromodomain inhibitors
IN2014DN10670A (es)
MX2015004362A (es) Derivados de ketamina.
IN2015DN01151A (es)
EA201201658A1 (ru) Производные пиперидина и их применение для лечения метаболических нарушений
MX2016003522A (es) Derivados de quinazolinas y su uso como inhibidores de la adn metiltransferasa.